Join to View Full Profile
4501 X StSuite 3019Sacramento, CA 95817
Phone+1 916-734-0517
Fax+1 916-734-7946
Are you Dr. Sangha?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Randeep Sangha, MD is an oncologist in Sacramento, California. He is currently licensed to practice medicine in California.
Education & Training
University of AlbertaClass of 2002
Certifications & Licensure
CA State Medical License 2007 - 2025
Publications & Presentations
PubMed
- 1 citationsA first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lym...Randeep Sangha, Rahima Jamal, Jennifer Spratlin, John Kuruvilla, Laurie H Sehn
Investigational New Drugs. 2024-08-01 - 173 citationsFirst-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 TrialLuis Paz-Ares, Suresh S. Ramalingam, Tudor-Eliade Ciuleanu, Jong Seok Lee, László Urbán
Journal of Thoracic Oncology. 2021-10-12 - 12 citationsRetrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors.A. Gibson, Adrian Box, Michelle Dean, A. Elegbede, Desiree Hao
JTO Clinical and Research Reports. 2021-04-01
Press Mentions
Pacylex Presents Evidence Supporting Advancement of PCLX-001 for Treatment of AML at AACR 2022April 8th, 2022- Pacylex Pharmaceuticals Announces Publication in Current Oncology of First Clinical Experience with an N-myristoyltransferase (NMT) Inhibitor in a Patient with Diffuse Large B-cell Lymphoma (DLBCL)March 14th, 2022
- Pacylex Presented Initial Clinical Experience with PCLX-001 in Patients at ASH 2021December 13th, 2021
- Join now to see all
